Delivery Order SPE2DB22D2007-SPE2DB24FH9BC
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $12,975.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,559,450,627 units of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The contract has an ultimate completion date of December 27, 2022 and is structured as a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,378.24, is for the delivery of 4,567,037,738 units of the antiviral drug Oseltamivir Phosphate 75 mg capsules. The contract is a firm fixed-price Delivery Order with a completion date of January 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $8,797.52 firm fixed-price delivery order is for the supply of 4,565,862,354 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of September 19, 2024 and does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, is a major supplier of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,283,081 units of the antiviral drug Oseltamivir Phosphate 75 mg capsules. The firm-fixed-price delivery order, valued at $1,382.20, has a completion date of January 10, 2024 and does not utilize any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,328.80 Firm Fixed Price Delivery Order is for the supply of 4566728790 units of Oseltamivir Phosphate 75 mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of 4,559,457,678 units of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The $1,573.55 fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 28, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of 4,566,780,044 units of the pharmaceutical product Oseltamivir Phosphate 75 mg capsules. The award, valued at $3,113.29, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 23, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a...
- This contract award, valued at $1,870.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,640,790 units of the drug Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract does not have a set-aside designation, indicating open competition. It is a firm-fixed price delivery order with a performance period extending to December 9,...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,706.51 firm fixed-price delivery order is for the purchase of 4,565,313,607 units of Oseltamivir 75mg, a medication used to treat and prevent influenza. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of 4,567,254,103 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $1,379.28 firm fixed-price delivery order contract has a completion date of February 13, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical,...